Drug profile · INN
levomepromazine
LEVOPROME
levomepromazine (LEVOPROME) is a d2-like dopamine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — levomepromazine
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
levomepromazine (LEVOPROME) is a d2-like dopamine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
D2-like dopamine receptor antagonist
Primary target: D2-like dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is levomepromazine?
levomepromazine (LEVOPROME) is a d2-like dopamine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for levomepromazine?
LEVOPROME is a marketed brand name for levomepromazine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levomepromazine?
levomepromazine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.